$CAI News
Last published 1w ago
- 1w agoCAICaris Life Sciences, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoCAICARIS THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL - CARIS LIFE SCIENCES INCEarnings Call TranscriptsGood afternoon, everyone, and welcome to the Karis Life Sciences third quarter 2026 earnings call. My name is Lisa, and I will be your conference operator today. All participants on a listen-only mode. After the prepared
- 3w agoCAICaris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer DetectionPR NewswireNew campaign connects AI-powered performance insights linking advanced molecular intelligence to help detect cancer in earlier stagesIRVING, Texas, Oct. 19, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ:CAI), a
- 3w agoCAICaris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026PR NewswireIRVING, Texas, Oct. 15, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ:CAI), a leading TechBio company, today announced it will report third quarter 2026 financial results on Wednesday, November 4, 2026.Caris Life
- 4w agoCAICaris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026PR NewswireEight posters will feature AI-driven approaches to treatment prediction, risk stratification and biomarker discovery advancing precision medicine across multiple cancer typesIRVING, Texas, Oct. 14, 2026 /PRNewswire/ --
- 2mo agoCAICaris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris DetectPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the launch of its new national campaign titled, "Math," featuring the...
- 2mo agoCAICaris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung CancerPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced that researchers from Caris and the Caris Precision Oncology Alliance® ...
- 2mo agoCAICaris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic CancerPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the publication of a study in npj Precision Oncology describing the...
- 3mo agoCAICARIS SECOND QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL - CARIS LIFE SCIENCES INCEarnings Call TranscriptsGood day, everyone, and welcome to the Karis Life Sciences Q2 2026 earnings call. My name is Tanya, and I'll be your conference operator today. All participants are in a listen-only mode. After the prepared remarks, ther
- 3mo agoCAICaris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue GuidancePR NewswireCaris Life Sciences, Inc. (Nasdaq: CAI), a leading TechBio company actively developing and commercializing solutions to transform healthcare, today...
- 3mo agoCAICaris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026PR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced it will report second quarter 2026 financial results on Wednesday,...
- 4mo agoCAICaris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC TestingPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced it...
- 4mo agoCAICaris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood TestPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the ...
- 4mo agoCAICaris Life Sciences Announces Dual Listing on NYSE TexasPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the...
- 5mo agoCAICaris Life Sciences Announces Share Repurchase ProgramPR NewswireCaris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio company and precision medicine pioneer, today...
- 5mo agoCAICaris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic TestingPR NewswireCaris Life Sciences®, Inc. (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...
- 6mo agoCAICaris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer SeekPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 6mo agoCAIMBQIFMDAINNOX+1Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare OpportunitiesGlobeNewswireAUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and
- 6mo agoCAI2026 GLOBAL HEALTHCARE CONFERENCE - CARIS LIFE SCIENCES INCEarnings Call TranscriptsHi, everyone. Welcome to the Bank of America Conference. I'm Avantika Thabria from the Lifescience Tools and Diagnostics team. With us, we have Milan Radovich, the CSO, Brian Brill, Vice Chairman, Bobby Hill, Senior Vice
- 6mo agoCAICaris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene PanelsPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a...
- 6mo agoCAICaris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing AuthorizationPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced that ...
- 6mo agoCAICaris Life Sciences Reports First Quarter 2026 Financial ResultsPR NewswireCaris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient centric, next-generation AI TechBio company and precision medicine pioneer, today...
- 6mo agoCAICaris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of DiagnosisPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the...
- 6mo agoCAICaris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid MalignanciesPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient‑centric, next‑generation AI TechBio company and precision medicine pioneer, today announced...
- 6mo agoCAICaris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma PatientsPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced the...
- 6mo agoCAICaris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare ConferencePR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 6mo agoCAICaris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026PR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it ...
- 6mo agoCAICaris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer CenterPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 7mo agoCAICaris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer PatientsPR NewswireCaris Life Sciences®, Inc. (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...
- 7mo agoCAICaris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC PatientsPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 7mo agoCAICaris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid MalignanciesPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced the...
- 7mo agoCAICaris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris DetectPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 7mo agoCAICaris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung CancerPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced the...
- 7mo agoCAICaris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026PR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 7mo agoCAICaris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness MonthPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, is recognizing...
- 7mo agoCAICaris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer PatientsPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, published a study...
- 8mo agoCAICaris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian CancerPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 8mo agoCAICaris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual MeetingPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 8mo agoCAICaris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic CancerPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the ...
- 8mo agoCAICaris Life Sciences Completes Interim Readout of Achieve 1 StudyPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced an ...
- 8mo agoCAICaris Fourth Quarter 2025 Financial Results Conference Call - CARIS LIFE SCIENCES INCEarnings Call TranscriptsGood afternoon, everyone, and welcome to the CARES Life Sciences Q4 2025 Earnings Call. My name is Dana, and I will be your coordinator today. At this time, all participants are on the listen-only mode. After the speaker
- 8mo agoCAICaris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 OutlookPR NewswireCaris Life Sciences®, Inc. (NASDAQ: CAI), a leading, patient centric, next-generation AI TechBio company and precision medicine pioneer, today...
- 8mo agoCAICaris Launches Proprietary AI Insights Signature Which Deepens Understanding of Response to Breast Cancer Patients' Oral Chemotherapy DrugPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a...
- 8mo agoCAICaris Life Sciences to Participate in the TD Cowen 46th Annual Health Care ConferencePR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 9mo agoCAICaris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26PR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it ...
- 9mo agoCAICaris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab DeruxtecanPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a...
- 10mo agoCAICaris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 ResultsPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 10mo agoCAICaris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris DetectPR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a...
- 10mo agoCAICaris Life Sciences to Present at the 44th Annual J.P. Morgan Healthcare ConferencePR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...
- 10mo agoCAIThe Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer InstitutePR NewswireCaris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...